Literature DB >> 16159088

Extracerebral organ dysfunction in the acute stage after aneurysmal subarachnoid hemorrhage.

Wouter J Schuiling1, Paul J W Dennesen, Gabriël J E Rinkel.   

Abstract

In patients with aneurysmal subarachnoid hemorrhage (SAH), secondary complications are an important cause of morbidity and case fatality. Delayed cerebral ischemia and hydrocephalus are important intracranial secondary complications. Potentially treatable extracranial complications are also frequently observed, and some are related to the occurrence of delayed cerebral ischemia and outcome. In addition to the occurrence of an inflammatory response and metabolic derangements, cardiac and pulmonary complications are the most common extracranial complications. This article provides an overview of the most common extracranial complications in patients with SAH and describes their effects on outcome and delayed cerebral ischemia.

Entities:  

Mesh:

Year:  2005        PMID: 16159088     DOI: 10.1385/NCC:3:1:001

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  85 in total

1.  Cardiac troponin I predicts myocardial dysfunction in aneurysmal subarachnoid hemorrhage.

Authors:  N Parekh; B Venkatesh; D Cross; A Leditschke; J Atherton; W Miles; A Winning; A Clague; C Rickard
Journal:  J Am Coll Cardiol       Date:  2000-10       Impact factor: 24.094

2.  Magnesium sulfate therapy after aneurysmal subarachnoid hemorrhage.

Authors:  Richard S Veyna; Donald Seyfried; Don G Burke; Chris Zimmerman; Mark Mlynarek; Victoria Nichols; Anna Marrocco; Ajith J Thomas; Panayiotis D Mitsias; Ghiaus M Malik
Journal:  J Neurosurg       Date:  2002-03       Impact factor: 5.115

3.  Neurogenic pulmonary edema and other mechanisms of impaired oxygenation after aneurysmal subarachnoid hemorrhage.

Authors:  Paul M Vespa; Thomas P Bleck
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

4.  Reversible left ventricular dysfunction after subarachnoid hemorrhage.

Authors:  L R Handlin; L H Kindred; G D Beauchamp; J L Vacek; S K Rowe
Journal:  Am Heart J       Date:  1993-07       Impact factor: 4.749

5.  Prognostic significance of hypernatremia and hyponatremia among patients with aneurysmal subarachnoid hemorrhage.

Authors:  Adnan I Qureshi; M Fareed K Suri; Gene Y Sung; Robert N Straw; Abutaher M Yahia; Mustafa Saad; Lee R Guterman; L Nelson Hopkins
Journal:  Neurosurgery       Date:  2002-04       Impact factor: 4.654

6.  Pulmonary function and radiographic abnormalities related to neurological outcome after aneurysmal subarachnoid hemorrhage.

Authors:  A Gruber; A Reinprecht; H Görzer; P Fridrich; T Czech; U M Illievich; B Richling
Journal:  J Neurosurg       Date:  1998-01       Impact factor: 5.115

7.  The use of cardiac troponin-I (cTnI) to determine the incidence of myocardial ischemia and injury in patients with aneurysmal and presumed aneurysmal subarachnoid hemorrhage.

Authors:  M B Horowitz; D Willet; J Keffer
Journal:  Acta Neurochir (Wien)       Date:  1998       Impact factor: 2.216

8.  Relationship between leukocytosis and ischemic complications following aneurysmal subarachnoid hemorrhage.

Authors:  A Spallone; M Acqui; F S Pastore; B Guidetti
Journal:  Surg Neurol       Date:  1987-03

9.  The spectrum of pulmonary edema: differentiation of cardiogenic, intermediate, and noncardiogenic forms of pulmonary edema.

Authors:  C L Sprung; E C Rackow; I A Fein; A I Jacob; S K Isikoff
Journal:  Am Rev Respir Dis       Date:  1981-12

10.  Noradrenaline concentrations and electrocardiographic abnormalities after aneurysmal subarachnoid haemorrhage.

Authors:  P J Brouwers; H G Westenberg; J Van Gijn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-05       Impact factor: 10.154

View more
  6 in total

Review 1.  Anemia and transfusion after subarachnoid hemorrhage.

Authors:  Peter D Le Roux
Journal:  Neurocrit Care       Date:  2011-09       Impact factor: 3.210

2.  Immune cells subpopulations in cerebrospinal fluid and peripheral blood of patients with Aneurysmal Subarachnoid Hemorrhage.

Authors:  Leandro Moraes; Sofía Grille; Paula Morelli; Rafael Mila; Natalia Trias; Andreína Brugnini; Natalia LLuberas; Alberto Biestro; Daniela Lens
Journal:  Springerplus       Date:  2015-04-23

Review 3.  The harmful effects of subarachnoid hemorrhage on extracerebral organs.

Authors:  Sheng Chen; Qian Li; Haijian Wu; Paul R Krafft; Zhen Wang; John H Zhang
Journal:  Biomed Res Int       Date:  2014-07-07       Impact factor: 3.411

Review 4.  The Potential Therapeutic Effects of Artesunate on Stroke and Other Central Nervous System Diseases.

Authors:  Shilun Zuo; Qiang Li; Xin Liu; Hua Feng; Yujie Chen
Journal:  Biomed Res Int       Date:  2016-12-27       Impact factor: 3.411

5.  Anti-inflammatory effects of Simvastatin in patients with acute intracerebral hemorrhage in an intensive care unit.

Authors:  Xiurong Zhou; Jiafeng Chen; Chengdong Wang; Lili Wu
Journal:  Exp Ther Med       Date:  2017-10-16       Impact factor: 2.447

6.  High-sensitivity C-reactive protein as a predictive factor of acute kidney injury following aneurysmal subarachnoid hemorrhage: a prospective observational study.

Authors:  Bi-Hui Yang; Qiu He; Chen-Yu Ding; De-Zhi Kang; Qing-Xi Tang
Journal:  Acta Neurochir (Wien)       Date:  2019-07-17       Impact factor: 2.216

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.